PlainRecalls

Marlex Pharmaceuticals, Inc.

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Sep 13, 2023

Subscribe to new Marlex Pharmaceuticals, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Marlex Pharmaceuticals, Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,815 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,815 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 1 category
  • LATEST Sep 13, 2023
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Marlex Pharmaceuticals, Inc. accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Marlex Pharmaceuticals, Inc. sits among 14,151 recalling firms

Marlex Pharmaceuticals, Inc. ranks 3,815th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Marlex Pharmaceuticals, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3815th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Marlex Pharmaceuticals, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Marlex Pharmaceuticals, Inc. holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Sep 13, 2023

Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC 10135-0748-01
FDA Drug Critical Sep 13, 2023

Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01
FDA Drug Moderate Oct 9, 2013

Acetaminophen Tablets, 500 mg, 100-count bottles, Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, List No. 152, NDC 10135-152-01, UPC 3 10135 15201 8.

Marlex Pharmaceuticals, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Ajanta Pharma Ltd. 3

Frequently Asked Questions

How many federal recall notices name Marlex Pharmaceuticals, Inc.? ▼
PlainRecalls indexes 3 distinct federal recall events naming Marlex Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Marlex Pharmaceuticals, Inc. sit among other recalling firms? ▼
Marlex Pharmaceuticals, Inc. ranks #3,815 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Marlex Pharmaceuticals, Inc.'s notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates Marlex Pharmaceuticals, Inc.'s filing book? ▼
Filings for Marlex Pharmaceuticals, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Marlex Pharmaceuticals, Inc.: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Marlex Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026